Forbes -
13 Nov 2015 22:11
In trading on Friday, the SPDR S&P Pharmaceuticals ETF (XPH) is outperforming other ETFs, up about 2.4% on the day. Components of that ETF showing particular strength include shares of Mylan (MYL), up about 13.4% and shares of Impax Laboratories (IPXL), up about 9.3% on the day.
Share this Article